Fact CheckerSign in

NCT04798651Recruiting

Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 26 Oct 2026

Brief summary (registry, in English)

The study aims at identifying the type of B and CD4 T cell subsets with pathogenic properties in the different clinical forms of multiple sclerosis. This research might open new therapeutic approaches for the treatment of multiple sclerosis particularly progressive MS.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
11 Mar 2021
Start date
30 Sept 2021
Primary completion date
30 Sept 2027
Lead sponsor
University Hospital, Bordeaux
NCT number
NCT04798651

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 30 Sept 2021 to the primary completion date, 30 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)

Other

  • Pregnant or breastfeeding women,

Who the study is looking for

  • male or female subjects ;
  • Age ≥ 18 years;
  • subjects with MS defined by 2010 revised McDonald criteria or presenting a clinical isolated syndrome;
  • patients for which a blood draw and / or lumbar puncture to collect CSF is performed for diagnostic or therapeutic purpose;
  • affiliated to an health insurance system;
  • and who agree to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Bordeaux - service de neurologie
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.